Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,090 across all filing types
Latest filing 2023-02-27 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Horizon Therapeutics plc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details shareholdings and dealings by a person with interests in relevant securities (Citadel Group) in relation to an offeror/offeree (Horizon Therapeutics PLC). This type of disclosure is specifically designed to report major shareholding changes and market dealings during a takeover process. Since it does not fit into the other specific categories like M&A activity (which usually refers to the company's own merger announcements) or director dealings, it is classified as a Major Shareholding Notification (MRQ).
2023-02-27 English
Form 8.3 - Horizon Therapeutics plc
Major Shareholding Notification Classification · 97% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details shareholdings and dealings by a person with interests in relevant securities representing 1% or more of a company (Horizon Therapeutics PLC) involved in a takeover. This type of disclosure is a specific regulatory requirement for transparency during M&A activity and does not fit into the other categories like M&A announcements (TAR) or general regulatory filings (RNS) as it is a specific disclosure form.
2023-02-24 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a mandatory regulatory filing under the UK Takeover Code. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more in a company involved in a takeover (Mediclinic International PLC). Since this is a specific regulatory disclosure regarding shareholdings and dealings during a takeover period, it falls under the 'Regulatory Filings' category as the most appropriate classification.
2023-02-24 English
Form 8.3 - Horizon Therapeutics plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more in a company involved in a takeover (Horizon Therapeutics PLC). This type of disclosure is a specific regulatory requirement for major shareholders or entities involved in M&A activity to report their positions and transactions. Since it does not fit into the specific 'M&A Activity' (TAR) category (which is usually for company-level announcements) or 'Major Shareholding Notification' (MRQ) (which is for crossing thresholds), it is best classified as a Regulatory Filing (RNS) as it is a mandatory disclosure submitted to a Regulatory Information Service.
2023-02-23 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details shareholdings, derivative positions, and recent dealings in Mediclinic International PLC by Citadel Group. Since this is a specific regulatory disclosure regarding shareholding thresholds and takeover-related activity, it falls under the 'Major Shareholding Notification' category.
2023-02-23 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 98% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details shareholdings, derivative positions, and recent dealings. Since this is a specific regulatory disclosure form related to takeover activity and does not fit into the other categories like M&A (which usually refers to the corporate announcement of the deal itself) or Major Shareholding Notification (which is a different regulatory threshold), it is best classified as a Regulatory Filing (RNS).
2023-02-22 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.